SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $11,000 | -57.7% | 42,659 | -60.2% | 0.00% | -100.0% |
| Q1 2016 | $26,000 | -60.6% | 107,071 | -42.8% | 0.00% | 0.0% |
| Q4 2015 | $66,000 | -45.9% | 187,207 | +243.2% | 0.00% | -50.0% |
| Q2 2015 | $122,000 | -27.4% | 54,555 | -37.2% | 0.00% | -33.3% |
| Q1 2015 | $168,000 | +48.7% | 86,827 | +104.3% | 0.00% | +50.0% |
| Q4 2014 | $113,000 | -57.8% | 42,494 | -52.4% | 0.00% | -60.0% |
| Q3 2014 | $268,000 | +44.9% | 89,189 | +96.7% | 0.01% | +66.7% |
| Q2 2014 | $185,000 | +110.2% | 45,354 | +121.2% | 0.00% | +200.0% |
| Q1 2014 | $88,000 | +4.8% | 20,504 | +54.0% | 0.00% | 0.0% |
| Q3 2013 | $84,000 | – | 13,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |